4 results
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
life cycle. If started early, ART provides a normal lifespan, prevents immunodeficiency and stops the spread of HIV. However, treatment does not provide
F-1
EX-10.9
IMCR
Immunocore Holdings plc
15 Jan 21
Registration statement (foreign)
4:57pm
for the Licensed Products in the Territory where appropriate, such as for Licensed Product life cycle management;
(e) review and approve the protocols for all
DRS/A
EX-10.8
IMCR
Immunocore Holdings plc
22 Dec 20
Draft registration statement (amended)
12:00am
for the Licensed Products in the Territory where appropriate, such as for Licensed Product life cycle management;
(e) review and approve the protocols for all
- Prev
- 1
- Next